These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 12701394)
41. Wilson disease: pathogenesis and clinical considerations in diagnosis and treatment. Rosencrantz R; Schilsky M Semin Liver Dis; 2011 Aug; 31(3):245-59. PubMed ID: 21901655 [TBL] [Abstract][Full Text] [Related]
42. Twenty-four novel mutations in Wilson disease patients of predominantly European ancestry. Cox DW; Prat L; Walshe JM; Heathcote J; Gaffney D Hum Mutat; 2005 Sep; 26(3):280. PubMed ID: 16088907 [TBL] [Abstract][Full Text] [Related]
43. Copper transport and its defect in Wilson disease: characterization of the copper-binding domain of Wilson disease ATPase. Sarkar B J Inorg Biochem; 2000 Apr; 79(1-4):187-91. PubMed ID: 10830865 [TBL] [Abstract][Full Text] [Related]
44. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Wu J; Forbes JR; Chen HS; Cox DW Nat Genet; 1994 Aug; 7(4):541-5. PubMed ID: 7951327 [TBL] [Abstract][Full Text] [Related]
45. Wilson's disease: a challenging diagnosis. Clinical manifestations and diagnostic procedures in 12 patients. Hancu A; Mihai MC; Axelerad AD Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):58-63. PubMed ID: 21682185 [TBL] [Abstract][Full Text] [Related]
46. [Copper metabolism and genetic disorders]. Shimizu N Nihon Rinsho; 2016 Jul; 74(7):1151-5. PubMed ID: 27455805 [TBL] [Abstract][Full Text] [Related]
47. H714Q mutation in Wilson disease is associated with late, neurological presentation. Houwen RH; Juyn J; Hoogenraad TU; Ploos van Amstel JK; Berger R J Med Genet; 1995 Jun; 32(6):480-2. PubMed ID: 7666402 [TBL] [Abstract][Full Text] [Related]
48. Molecular regulation of copper excretion in the liver. Wijmenga C; Klomp LW Proc Nutr Soc; 2004 Feb; 63(1):31-9. PubMed ID: 15099406 [TBL] [Abstract][Full Text] [Related]
49. Pathogenesis of Wilson disease. Scheiber IF; Brůha R; Dušek P Handb Clin Neurol; 2017; 142():43-55. PubMed ID: 28433109 [TBL] [Abstract][Full Text] [Related]
50. Wilson disease. Langner C; Denk H Virchows Arch; 2004 Aug; 445(2):111-8. PubMed ID: 15205951 [TBL] [Abstract][Full Text] [Related]
51. Wilson disease missense mutations in ATP7B affect metal-binding domain structural dynamics. Shanmugavel KP; Kumar R; Li Y; Wittung-Stafshede P Biometals; 2019 Dec; 32(6):875-885. PubMed ID: 31598802 [TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical determination of the Wilson Copper-transporting P-type ATPase in the brain tissues of the rat. Saito T; Okabe M; Hosokawa T; Kurasaki M; Hata A; Endo F; Nagano K; Matsuda I; Urakami K; Saito K Neurosci Lett; 1999 Apr; 266(1):13-6. PubMed ID: 10336172 [TBL] [Abstract][Full Text] [Related]
54. Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia. Attri S; Sharma N; Jahagirdar S; Thapa BR; Prasad R Pediatr Res; 2006 Apr; 59(4 Pt 1):593-7. PubMed ID: 16549536 [TBL] [Abstract][Full Text] [Related]
55. Wilson disease: lessons from an island population. Tanner S J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):6-7. PubMed ID: 21832954 [No Abstract] [Full Text] [Related]
56. Not all absent serum ceruloplasmin is Wilson disease: a review of aceruloplasminemia. Harris ZL J Investig Med; 2002 Sep; 50(5):236S-238S. PubMed ID: 12227652 [No Abstract] [Full Text] [Related]
57. Determination of the frequencies of ten allelic variants of the Wilson disease gene (ATP7B), in pooled DNA samples. Olsson C; Waldenström E; Westermark K; Landegre U; Syvänen AC Eur J Hum Genet; 2000 Dec; 8(12):933-8. PubMed ID: 11175281 [TBL] [Abstract][Full Text] [Related]
58. A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease. Greig JA; Nordin JML; Smith MK; Ashley SN; Draper C; Zhu Y; Bell P; Buza EL; Wilson JM Hum Gene Ther Clin Dev; 2019 Mar; 30(1):29-39. PubMed ID: 30693797 [TBL] [Abstract][Full Text] [Related]